References
- Filipo R, Attanasio G, Russo FY, et al. Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss. Audiol Neurootol. 2014;19(4):225–233.
- Filipo R, Covelli E, Balsamo G, et al. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol. 2010;130(11):1209–1213.
- Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol. 2016;273(9):2271–2278.
- Plaza G, Herráiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg. 2007;137(1):74–78.
- Sennaroglu L, Sennaroglu G, Gursel B, et al. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere’s disease. Otolaryngol Head Neck Surg. 2001;125(5):537–543.
- Juan ID, Linthicum FH Jr. Round window fibrous plugs. Otol Neurotol. 2010;31(8):1354–1355.
- Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 2000;122(4):521–528.
- Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol. 2007;28(8):1124–1130.
- Bird PA, Murray DP, Zhang M, et al. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol. 2011;32(6):933–936.
- Sugiyama K, Kawada T, Sato H, et al. Comparison of suppressive potency between prednisolone and prednisolone sodium succinate against mitogen-induced blastogenesis of human peripheral blood mononuclear cells in-vitro. J Pharm Pharmacol. 2001;53(5):727–733.
- Zhang M, Moore GA, Jensen BP, et al. Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(1):17–24.
- Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: influence of drug properties on intratympanic applications. Hear Res. 2018;368:28–40.
- Devantier L, Djurhuus BD, Hougaard DD, et al. Intratympanic steroid for Menière’s disease: a systematic review. Otol Neurotol. 2019;40(6):806–812.
- Rutt AL, Hawkshaw MJ, Sataloff RT. Incidence of tympanic membrane perforation after intratympanic steroid treatment through myringotomy tubes. Ear Nose Throat J. 2011;90(4):E21.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109(7 Pt 2):1–17.
- Plontke SK, Plinkert PK, Plinkert B, et al. Transtympanic endoscopy for drug delivery to the inner ear using a new microendoscope. Adv Otorhinolaryngol. 2002;59:149–155.
- Bozzato A, Bozzato V, Al Kadah B, et al. A novel multipurpose modular mini-endoscope for otology. Eur Arch Otorhinolaryngol. 2014;271(12):3341–3348.
- Shaul C, Venkatagiri PK, Lo J, et al. Glucocorticoid for hearing preservation after cochlear implantation: a systemic review and meta-analysis of animal studies. Otol Neurotol. 2019;40(9):1178–1185.